• Latest Posts
In Depth 19 Oct 2023

Biotech’s battle against NASH: The ongoing pursuit of an effective treatment

In Depth 11 Dec 2023

European patents in biotech: how to prevent invalid patents?

In Depth 15 Nov 2023

Beyond oil and gas: Biotech’s significant place in the Qatar Investment Authority’s strategy

In Depth 7 Dec 2023

The biggest private biotech investments in November 2023

In Depth 30 Nov 2023

Could an Alzheimer’s vaccine make treatment more affordable?

In Depth 27 Nov 2023

How are R&D Tax Incentives shaping Australia’s biotech future?

In Depth 23 Nov 2023

The next frontier in immunotherapy? CAR-Macrophages as a novel cancer treatment strategy

In Depth 22 Nov 2023

Apellis’ Syfovre vs Astellas’ Izervay: the battle for a geographic atrophy treatment

In Depth 16 Nov 2023

Meet the ‘biotech mafia’: how specialized biotech VC firms are dominating industry funding once again

In Depth 9 Nov 2023

Blood tests for Alzheimer’s: a hit or a miss?

In Depth 8 Nov 2023

Promising cure for COPD: is a breakthrough treatment within reach?